仁和药业(000650.SZ)控股股东拟减持不超300万股

Core Viewpoint - Renhe Pharmaceutical (000650.SZ) announced that its controlling shareholder, Renhe (Group) Development Co., Ltd., plans to reduce its shareholding by up to 3 million shares within three months after the announcement, representing a maximum reduction of 0.2143% of the company's total share capital [1] Summary by Sections - Shareholding Reduction Plan - The controlling shareholder intends to reduce its stake through centralized bidding or block trading [1] - The maximum number of shares to be sold is 3 million [1] - The reduction will occur within three months following the announcement, starting 15 trading days after the disclosure [1]